Vision
Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD
- Authors
- Holz FG … Sahel JA25 authors
- Institution
- University of Bonn; Hôpital des Quinze-Vingts; LMU University Eye Hospital
- Publication
- New England Journal of MedicineN Engl J Med 2026;394(3):232–242 · 20 Oct 2025
- Status
- Primary source
The 60-second view
- What problem?
- Geographic atrophy destroys central vision and no therapy had been shown to restore it.
- What did they do?
- Implanted a photovoltaic microarray under the retina in 38 participants; camera glasses project near-infrared images onto it.
- What changed?
- 26 of the 32 participants assessed at 12 months improved by at least 0.2 logMAR with the system on.
- Why does it matter?
- It is the strongest clinical evidence so far that a neural prosthesis can restore a lost sense at a scale relevant to a common disease.
Method
- Participants
- 38 people with geographic atrophy and visual acuity of at least 1.2 logMAR; 32 assessed at 12 months
- Interface
- Subretinal photovoltaic implant with near-infrared projecting glasses
- Signal
- Photovoltaic stimulation of inner retinal neurons
- Task
- Visual acuity with and without the system at 6 and 12 months
- Decoder
- Not applicable; image processing in the wearable
Results
- 26 of 32 (81%)
- Clinically meaningful improvement at 12 months
- 95% CI 64–93
- 38
- Participants implanted
Strength of evidencePeer reviewed, open-label, multicentre, baseline-controlled. Serious adverse events related to the procedure or device were reported and are detailed in the paper.
Figures are quoted from the published abstract and were checked on 3 Oct 2026.
Limitations
- Open-label, single-group design.
- Six participants were not assessed at 12 months.
- Restores central form vision through glasses, not natural sight.
What this could enable
The first authorised device for restoring form vision in this condition, CE-marked in 2026.
Primary source
- 01
Holz FG et al. N Engl J Med 2026;394(3):232–242 (opens in a new tab)
Peer reviewedNew England Journal of Medicine20 Oct 2025Checked against source 3 Oct 2026
DOI 10.1056/NEJMoa2501396